Zhili Zheng

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, China Academy of Chinese Medical Sciences, Guang’anmen Hospital · ORCID：0000-0002-5505-2022

发表论文 87 篇 · 总被引 15228 次 · h-index 50

代表论文

• Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer (2018 · Nature Medicine · 被引 788)
• Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers (2022 · Science · 被引 474)
• Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma (2019 · Journal of Immunotherapy · 被引 385)
• Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors (2022 · Cancer Immunology Research · 被引 183)
• Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy (2019 · Cancer Immunology Research · 被引 65)
• Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing (2021 · Journal for ImmunoTherapy of Cancer · 被引 62)